相关临床试验
26
3 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
2010
进行中（未招募）
2
7.7%
已完成
16
61.5%
尚未招募
1
3.9%
招募中
5
19.2%
终止
1
3.9%
暂无批准数据
- The BOHEMIA trial, the largest study on ivermectin for malaria to date, demonstrated a 26% reduction in new malaria infections when administered alongside standard bed nets in Kenya. - Over 20,000 participants in Kwale County, Kenya received monthly ivermectin doses for three consecutive months, showing significant malaria reduction with only mild, transient side effects. - The World Health Organization's vector control advisory group has reviewed the findings and recommended further studies, marking a potential breakthrough in malaria control strategies. - Beyond malaria prevention, ivermectin treatment provided additional benefits including reduced prevalence of scabies, head lice, and bed bugs in treated communities.
- USAID programs prevented 91 million deaths between 2001 and 2021, with an 83% funding cut now threatening to reverse decades of global health progress. - Tuberculosis programs face catastrophic disruption, with projections showing up to 4.4 million additional TB cases and 884,000 deaths in high-dependency countries. - The funding freeze affects 26 high-burden tuberculosis countries, with eight nations classified as highly dependent on US government support for their national TB programs. - Researchers warn the cuts could trigger health impacts comparable to a global pandemic, particularly devastating vulnerable populations in low- and middle-income countries.
